Search clinical trials for: Fluvoxamine

Total 72 results

Guangdong Provincial People's Hospital

Completed

Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder

Obsessive Compulsive Disorder

China
Chulalongkorn University
Washington University School of Medicine; Mahidol University; Ramathibodi Hospital and other collaborators

Completed

Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community

Treatment Efficacy

Thailand
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder

OCD

China
Novartis Pharmaceuticals

Completed

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors. (CTKI258A2120)

Advanced Solid Tumors, Excluding Breast Cancer

Netherlands, Switzerland, Denmark, United States
Sha'ar Menashe Mental Health Center

Unknown

Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients

SCHIZOPHRENIA 1 (Disorder)

Israel
Lingjiang Li

Recruiting

A Clinical Trial of Fluvoxamine for Melancholia

Depressive Disorder | Melancholia | Endogenous Depression

China
Susanna Naggie, MD
Vanderbilt University Medical Center; National Center for Advancing Translational...

Completed

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)

Covid19

United States
Guang Dong Provincial Mental Health Institute

Unknown

The Effect of Fluvoxamine on Polysonogram in Depressed Patients With Insomnia

Depression

China
Solvay Pharmaceuticals

Terminated

Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

Obsessive Compulsive Disorder

Japan
Susanna Naggie, MD
Vanderbilt University Medical Center; National Center for Advancing Translational...

Completed

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)

Covid19

United States
Hadassah Medical Organization

Completed

Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel

Drug Interactions Between Clopidogrel and Serotonin Reuptake Inhibitors
Solvay Pharmaceuticals

Completed

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

Major Depressive Disorder

Japan
AbbVie
Meiji Seika Pharma Co., Ltd.

Completed

A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder

Obsessive Compulsive Disorder
The Hospital for Sick Children

Completed

Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?

Autism

Canada
Karolinska Institutet

Completed

Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes

Depression

Sweden
Shanghai Mental Health Center

Completed

The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

China
Shanghai Mental Health Center

Completed

The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

China
Hadassah Medical Organization

Completed

Impact of Omeprazole and Fluvoxamine on Platelet Response to Clopidogrel

Drug Interaction of Clopidogrel

Israel
Taipei Medical University Hospital
National Health Research Institutes, Taiwan

Completed

Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine

Schizophrenia

Taiwan
Astellas Pharma Inc

Completed

Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

Healthy | Pharmacokinetics of Quetiapine

Japan
National Institute of Mental Health (NIMH)

Completed

Treatment of Youth With ADHD and Anxiety

Generalized Anxiety Disorder | Attention Deficit Hyperactivity Disorder | Social Phobia | Anxiety, Separation

United States
MODAG GmbH
Teva Pharmaceutical Industries, Ltd.; Quotient Sciences; Aptuit

Completed

A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)

Healthy Volunteers

United Kingdom
Shanghai Mental Health Center
First Affiliated Hospital Xi'an Jiaotong University; Chinese Academy of Sciences and other collaborators

Unknown

Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics (STEP-MDD)

Depressive Disorder

China
Heidelberg University

Completed

Interaction Between Fluvoxamine and Sildenafil

Healthy

Germany
Cardresearch

Recruiting

A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial (REVIVE)

Chronic Fatigue Syndrome | Long COVID-19 Syndrome

Brazil
Nanjing Medical University

Unknown

Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder

Major Depressive Disorder

China
Pfizer

Completed

Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.

Dermatitis, Atopic

Belgium
Capital Medical University

Recruiting

Electronic Training of Elderly Depression With Cognitive Impairment

Cognitive Impairment | Geriatric Depression

China
Massachusetts General Hospital
Medtronic - MITG

Completed

Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

Major Depressive Disorder
University Hospital, Lille
University of Pennsylvania; Institut National de la Santé Et de la Recherche... and other collaborators

Completed

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma (MesoPDT)

Malignant Pleural Mesothelioma

France
Centre Hospitalier Universitaire Vaudois
Hospices Civils de Lyon; University Hospital, Geneva; Central Hospital, Nancy...

Unknown

Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications

Depressive Disorder | Lactation

France, Switzerland
University Hospital, Geneva

Recruiting

Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status (Switch19)

Healthy

Switzerland
Cardresearch
McMaster University; Eiger BioPharmaceuticals; Cytel Inc.; Fastgrants; RainWater...

Recruiting

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

Covid19 | SARS-Associated Coronavirus

Brazil
Hoffmann-La Roche

Completed

A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy Volunteers

Healthy Volunteer

France
National Institute of Mental Health (NIMH)

Completed

Treatment for Anxiety in Children

Obsessive-Compulsive Disorder | Anxiety Disorders | Generalized Anxiety Disorder | Social Phobia | Separation Anxiety
Washington University School of Medicine
Balvi COVID Fund

Recruiting

Fluvoxamine for Long COVID-19

Long COVID

United States
SigmaDrugs Research Ltd.

Completed

Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients

Covid19

Hungary
Susanna Naggie, MD
Vanderbilt University Medical Center; National Center for Advancing Translational...

Active, not recruiting

ACTIV-6: COVID-19 Study of Repurposed Medications

Covid19

United States
Corcept Therapeutics

Completed

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Non-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight Gain

United States
Washington University School of Medicine
Cures Within Reach; Covid-19 Early Treatment Fund; McGill University Health Centre...

Completed

Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)

Covid19 | Coronavirus

United States, Canada
Washington University School of Medicine

Withdrawn

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia (FluCOP)

COVID-19 | Olfactory Disorder | Parosmia

United States
Washington University School of Medicine

Completed

A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection (STOP COVID)

COVID 19 | Coronavirus

United States
Moscow Research Institute of Psychiatry
Abbott

Completed

Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

Recurrent Depressive Disorder

Russian Federation
Sha'ar Menashe Mental Health Center

Unknown

Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function

Schizophrenia

Israel
Vanda Pharmaceuticals

Completed

Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine

Healthy Volunteers

United States
AstraZeneca
Parexel

Completed

A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects

Healthy Male Subjects

United States
Asan Medical Center

Suspended

Fluvoxamine for Adults With Mild to Moderate COVID-19

Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19

Korea, Republic of
Rogers Center for Research & Training, Inc.

Unknown

Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder

United States
AstraZeneca
Parexel

Completed

A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers

Healthy Volunteer/DDI Study

United Kingdom
Boehringer Ingelheim

Completed

Influence of Fluvoxamine on the Pharmacokinetics of BI 409306

Healthy

Germany

Search clinical trials for: Fluvoxamine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations